Salus Biomed has a unique, proprietary labeling and detection technique to readout bases beyond the optical diffraction limit. In sequencing, it increases the throughput and lowers the sequencing cost by many folds. In spatial omics studies, it allows one to observe fine details and molecular interactions with unparalleled resolution.

Our proprietary robot sequencers – RoboSeq – provide fully automated services for large scale genomic studies such as populational genome projects and the Human Cell Atlas Plan. Through fully integrated DNA extraction, library preparation, and automated sequencing, human errors are minimized to a negligible level.

Paired with super resolution detection techniques, ultra-high density biochips for sequencing and spatial omics studies are produced using proprietary nano-printing techniques. Biochips with pitches smaller than the optical diffraction limit are provided.

Combined with RoboSeq sequencing techniques, Salus Biomed provides ultra-large biochips as large as 140 x 140 mm² for spatial biology studies. It makes the study of tissue slices from a whole organ possible.